Pertuzumab/Trastuzumab Regimen

Preferred Label : Pertuzumab/Trastuzumab Regimen;

NCIt synonyms : Pertuzumab Trastuzumab; Pertuzumab Plus Trastuzumab; Pertuzumab/Trastuzumab; Pertuzumab-Trastuzumab Regimen; Herceptin-Perjeta;

NCIt related terms : Pertuzumab and Trastuzumab; Pertuzumab and Trastuzumab-zerc; Pertuzumab and Trastuzumab-pkrb; Pertuzumab and Trastuzumab-dkst; Pertuzumab and Trastuzumab-anns; Pertuzumab and Trastuzumab-herw; Pertuzumab and Trastuzumab-dttb; Pertuzumab and Trastuzumab-qyyp;

NCIt definition : A regimen consisting of pertuzumab and trastuzumab that may be used as a treatment for appendiceal adenocarcinoma, salivary gland tumors, breast, hepatobiliary and colorectal cancers.;

NCIt note : Source: NCCN Guidelines 2017;

NCI Metathesaurus CUI : CL524988;

Codes from synonyms : 9691; 128973; 128876; 129361; 129264; 129167; 129458; 129070;

Details

Origin ID

C138042;

UMLS CUI

C4527348;

Automatic exact mappings (from CISMeF team)
- pertuzumab and trastuzumab [ATC Code]
Est indiqué pour
- Early-Stage HER2 Positive Breast Cancer [Indication]
- HER2 positive breast cancer [MedDRA Preferred Term]
- Locally advanced breast cancer [MedDRA LLT]
- locally advanced breast cancer [Indication]
Semantic type(s)
- Therapeutic or Preventive Procedure [UMLS semantic type]
chemotherapy_regimen_has_component
- Pertuzumab [NCIt concept]
- Trastuzumab [NCIt concept]
concept_is_in_subset
- HemOnc Regimen Terminology [NCIt concept]
- Multi-agent Therapeutic Regimens [NCIt concept]
- Pharmacotherapy Regimens [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients